Patent Assignment
Reel/Frame 052696/0247
Security Interest
Recorded: 2020-05-19
Pages: 8
Assignor
ADC THERAPEUTICS SA
Executed: 2020-05-19
Assignee
DEERFIELD PARTNERS, L.P., AS GRANTEE
780 THIRD AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Properties
(31)
Polynucleotides and Polypeptide Sequences Involved in Cancer
Anti-Kidney Associated Antigen 1 (KAAG1) Antibodies
Antibodies That Specifically Block the Biological Activity of Kidney Associated Antigen 1 (KAAG1)
Antibodies Against Kidney Associated Antigen 1 and Antigen Binding Fragments Thereof
Pyrrolobenzodiazepine-Antibody Conjugates
Pyrrolobenzodiazepine-Antibody Conjugates
Pyrrolobenzodiazepine-Anti-CD22 Antibody Conjugates
Antibodies Against Kidney Associated Antigen 1 and Antigen Binding Fragments Thereof
Antibodies Against Kidney Associated Antigen 1 and Antigen Binding Fragments Thereof
Pyrrolobenzodiazepine-Antibody Conjugates
Humanized Anti-Axl Antibodies and Their Conjugates
Application:
15/566,639 →
Publication:
US 2018/0127505
Diagnostic Test Involving Anti-CD25-Adc
Application:
15/571,969 →
Publication:
US 2018/0142025
Antibodies Against Kidney Associated Antigen 1 and Antigen Binding Fragments Thereof
Antibodies That Specifically Block the Biological Activity of a Tumor Antigen
Application:
15/833,753 →
Publication:
US 2018/0369269
Polynucleotides and Polypeptide Sequences Involved in Cancer
Application:
15/863,594 →
Publication:
US 2018/0346563
Pyrrolobenzodiazepine-Anti-CD22 Antibody Conjugates
Pyrrolobenzodiazepine-Antibody Conjugates
Pyrrolobenzodiazepine-Antibody Conjugates
Method for Treating Breast Cancer
Combination Therapy with an Anti-Axl Antibody-Drug Conjugate
Pyrrolobenzodiazepine-Antibody Conjugates
Pyrrolobenzodiazepine-Antibody Conjugates
Combination Therapy with an Anti-Axl Antibody-Drug Conjugate
Application:
16/605,692 →
Publication:
US 2020/0129637
Combination Therapy
Application:
16/605,701 →
Publication:
US 2020/0405879
Combination Therapy with an Anti-CD25 Antibody-Drug Conjugate
Combination Therapy with an Anti-Psma Antibody-Drug Conjugate
Application:
16/605,710 →
Publication:
US 2020/0129638
Dosage Regimes for the Administration of an Anti-CD19 Adc
Dosage Regimes for the Administration of an Anti-CD25 Adc
Site-Specific Antibody-Drug Conjugates
Antibodies Against Kidney Associated Antigen 1 and Antigen Binding Fragments Thereof
Application:
16/707,482 →
Publication:
US 2021/0054067
Pyrrolobenzodiazepine-Antibody Conjugates
Application:
16/806,910 →
Publication:
US 2020/0405873
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 18, 2008
From: SOOKNANAN, ROY RABINDRANAUTH; TREMBLAY, GILLES BERNARD; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 022005/0351 →
Assignment of Assignor's Interest
Mar 29, 2012
From: TREMBLAY, GILLES BERNARD; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 027952/0754 →
Assignment of Assignor's Interest
Mar 29, 2012
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 027952/0500 →
Assignment of Assignor's Interest
Mar 19, 2013
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 030041/0918 →
Assignment of Assignor's Interest
Mar 19, 2013
From: TREMBLAY, GILLES BERNARD; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 030041/0863 →
Assignment of Assignor's Interest
Oct 17, 2013
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 031425/0017 →
Assignment of Assignor's Interest
Oct 31, 2013
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 031519/0773 →
Assignment of Assignor's Interest
Dec 12, 2013
From: TREMBLAY, GILLES BERNARD; MORAITIS, ANNA N.; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 031766/0935 →
Assignment of Assignor's Interest
Dec 12, 2013
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 031766/0876 →
Assignment of Assignor's Interest
Dec 12, 2013
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 031767/0056 →
Assignment of Assignor's Interest
Mar 22, 2016
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 038071/0421 →
Assignment of Assignor's Interest
Mar 22, 2016
From: TREMBLAY, GILLES BERNARD; MORAITIS, ANNA N.; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 038071/0075 →
Assignment of Assignor's Interest
Mar 22, 2016
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 038071/0204 →
Assignment of Assignor's Interest
Sep 20, 2016
From: VAN BERKEL, PATRICIUS HENDRIKUS CORNELIS
To: A.T. DEVELOPMENT SWITZERLAND SÀRL
Reel/Frame 039790/0855 →
Assignment of Assignor's Interest
Sep 20, 2016
From: HOWARD, PHILIP WILSON
To: MEDIMMUNE LIMITED
Reel/Frame 039791/0157 →
Assignment of Assignor's Interest
Sep 20, 2016
From: A.T. DEVELOPMENT SWITZERLAND SÀRL
To: ADC THERAPEUTICS S.A.
Reel/Frame 039790/0982 →
Corrective Assignment to Correct the Receiving Party Address Previously Recorded at Reel: 039791 Frame: 0157. Assignor(S) Hereby Confirms the Assignment.
Sep 22, 2016
From: HOWARD, PHILIP WILSON
To: MEDIMMUNE LIMITED
Reel/Frame 040107/0618 →
Assignment of Assignor's Interest
Jun 29, 2017
From: TREMBLAY, GILLES BERNARD; MORAITIS, ANNA N.; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 042863/0450 →
Assignment of Assignor's Interest
Jun 29, 2017
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 042863/0630 →
Assignment of Assignor's Interest
Jun 29, 2017
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 042863/0552 →
Assignment of Assignor's Interest
Jun 30, 2017
From: HOWARD, PHILIP WILSON
To: MEDIMMUNE LIMITED
Reel/Frame 042871/0804 →
Assignment of Assignor's Interest
Jun 30, 2017
From: HARTLEY, JOHN; VAN BERKEL, PATRICIUS HENRIKUS CORNELIS
To: ADC THERAPEUTICS SA
Reel/Frame 042871/0669 →
Assignment of Assignor's Interest
Jun 30, 2017
From: ALETHIA BIOTHERAPEUTICS INC.
To: ADC THERAPEUTICS SA
Reel/Frame 042880/0186 →
Assignment of Assignor's Interest
Dec 20, 2017
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 044450/0769 →
Assignment of Assignor's Interest
Dec 20, 2017
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 044450/0793 →